DEC 31, 2016 11:13 AM PST

Synthetic Molecules Created for Future Therapeutic Potential

WRITTEN BY: Carmen Leitch

Chemists working at the University of Oregon have created a new kind of molecule with the aim that when broken down by the body under specific conditions, the designer molecule would induce the release of hydrogen sulfide. That could bring therapeutics to the cellular level, aiming to repair cells damaged by stress such as that from a heart attack. The work is far from use in the clinic, but has potential for the future.

Illustration shows the delivery route of hydrogen sulfide to damaged cells based on two projects completed in the University of Oregon lab of Michael Pluth. / Credit: Illustration by Michael Pluth

The proof-of-concept work was published in portions in the Journal of the American Chemical Society last June, and in November in Angewandte Chemie. "We have discovered that small organic molecules can be engineered to release a molecule called carbonyl sulfide, which is the most prevalent sulfur-containing molecule in the atmosphere, but more importantly converts rapidly to hydrogen sulfide under biological conditions," explained a co-author on both reports, Michael Pluth, a Professor of Chemistry. "We developed and demonstrated a new mechanism to release small molecules that provide therapeutic hydrogen sulfide."

Hydrogen sulfide doesn’t spring to mind when considering therapies, and is known as a dangerous and toxic colorless gas in the environment. However, hydrogen sulfide is also made by mammals, including humans, and plays critical roles in cardiac health and molecular signaling. As such, figuring out how to get the body to produce restorative hydrogen sulfide has been a goal for many researchers for the past two decades. The Pluth lab has previously invented a probe that is able to detect the gas in biological samples, setting up a way to assay candidate donor molecules – either those purified from natural sources or synthesized in the lab.

In the event of a heart attack or blood flow constriction, levels of reactive oxygen species like hydrogen peroxide increase, Pluth said. The newly created molecules are able to react to an increased expression of reactive oxygen species. Hydrogen sulfide donors that are available tend to be molecules that act slowly, only donating hydrogen sulfide in a passive way.

These two studies together indicate that molecules can be engineered to release carbonyl sulfide and then hydrogen sulfide by putting a trigger into the molecule that starts the delivery process, Zhao said. "With this, you might be able to pick molecular events that are associated with conditions in which hydrogen sulfide might be beneficial, and then develop donor molecules able to deliver hydrogen sulfide under those conditions," he explained.

"The novelty for us was being able to use carbonyl sulfide as a source of hydrogen sulfide donation," commented Steiger, regarding the project she led. "This was a first. It opened up a whole new class of donor molecules."

The development of these hydrogen sulfide-releasing molecules is a goal because there is real potential for eventual therapeutic applications, Pluth said. "Having researchers nearby who are focused on translating basic science discoveries into market applications would facilitate further expansion of this work," he concluded.

As previously mentioned, hydrogen sulfide has been on the research radar for awhile. A report is described in the cheeky video above in which a doctor at the University of Exeter identified hydrogen sulfide, a gas in flatulence, as a possible cancer therapeutic.

Sources: AAAS/Eurekalert! via University of Oregon News, Journal of the American Chemical Society, Angewandte Chemie

About the Author
  • Experienced research scientist and technical expert with authorships on over 30 peer-reviewed publications, traveler to over 70 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
SEP 11, 2020
Drug Discovery & Development
Single Injection Sends Type 2 Diabetes into Remission
SEP 11, 2020
Single Injection Sends Type 2 Diabetes into Remission
Type 2 diabetes affects around 10% of people in the US. Although there is no cure for it, there are some well-known meth ...
SEP 11, 2020
Immunology
Study Reveals Tumor Defense Mechanism... And How to Beat It
SEP 11, 2020
Study Reveals Tumor Defense Mechanism... And How to Beat It
  P53 is an infamous process gene at the core of the development of tumors.  When P53  functional, it pau ...
SEP 08, 2020
Neuroscience
Synchronizing Brain Waves Could Help Dyslexia Effects
SEP 08, 2020
Synchronizing Brain Waves Could Help Dyslexia Effects
New research from the University of Geneva shows that adults with dyslexia can read more fluently with a non-invasive el ...
OCT 13, 2020
Immunology
Why Halloween Is Extra Scary for Kids With Peanut Allergies
OCT 13, 2020
Why Halloween Is Extra Scary for Kids With Peanut Allergies
A recent study showed that there is an 85 percent spike in peanut allergy anaphylaxis cases on Halloween. The study, per ...
NOV 17, 2020
Cell & Molecular Biology
Chronic Inflammation Lowers Levels of Aging-Linked Molecule
NOV 17, 2020
Chronic Inflammation Lowers Levels of Aging-Linked Molecule
Over the years, the molecule nicotinamide adenine dinucleotide (NAD+) has gone from being a player in some biochemical p ...
NOV 23, 2020
Genetics & Genomics
Unusual Mutation Acts as a Kind of Gene Therapy
NOV 23, 2020
Unusual Mutation Acts as a Kind of Gene Therapy
Clinicians have identified a patient with a rare inherited disorder that disrupts the production of fresh blood cells, a ...
Loading Comments...